Biofrontera Inc (BFRI)

Biofrontera Inc (BFRI) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $12M; returns 1 day +1.0%, 1 week -4.0%, 1 year -30.2%.

Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the commercialization of dermatological products, with a core focus on photodynamic therapy (PDT). The company's revenue is primarily generated from its drug-device combination: the Ameluz® topical gel and the associated RhodoLED® lamp series.

Groups BFRI belongs to

• Dermatology
• Biopharmaceutical
• Commercial Stage
• Commercial Stage Biotech
• Healthcare
• Pharmaceuticals
• Biotechnology
• Medical Devices

BFRI financial model: income statement, cash flow and balance sheet